Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jank

Showing results (391-400 of 417) with videos related to

Pageof 42
Sort By:
Human Pathology|September 24, 2023
LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinomaSvenja Kolb, Inga Hoffmann, Nanna Monjé, et al.
The Journal of Molecular Diagnostics : JMD|October 3, 2022
Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic ProfilingCarsten Denkert, Marcel Romey, Brad Swedlund, et al.
Journal of Neuroinflammation|November 13, 2021
Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A responseMarius Piepke, Bettina H Clausen, Peter Ludewig, et al.
Plos One|August 26, 2020
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trialPaul Jank, Claire Gehlhaar, Lederer Bianca, et al.
Plos One|September 1, 2021
Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trialPaul Jank, Claire Gehlhaar, Bianca Lederer, et al.
British Journal of Cancer|July 21, 2022
pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas-proposal for a new pT3a/pT3b subclassificationSebastian Foersch, Corinna Lang-Schwarz, Markus Eckstein, et al.
NPJ Breast Cancer|May 14, 2025
Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantificationKristin Galas, Moritz Gleitsmann, Julia Rey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical TrialsPaul Jank, Thomas Karn, Marion van Mackelenbergh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto TrialSibylle Loibl, Denise Treue, Jan Budczies, et al.
Virchows Archiv : an International Journal of Pathology|April 23, 2026
Optimization of Ki67 digital image analysis in breast cancer by automated tumor area identificationPaul Jank, Maximilian J Krämer, Michael Untch, et al.
Pageof 42

Showing results (391-400 of 417) with videos related to

Sort By:
Pageof 42
Human Pathology|September 24, 2023
LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinomaSvenja Kolb, Inga Hoffmann, Nanna Monjé, et al.
The Journal of Molecular Diagnostics : JMD|October 3, 2022
Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic ProfilingCarsten Denkert, Marcel Romey, Brad Swedlund, et al.
Journal of Neuroinflammation|November 13, 2021
Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A responseMarius Piepke, Bettina H Clausen, Peter Ludewig, et al.
Plos One|August 26, 2020
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trialPaul Jank, Claire Gehlhaar, Lederer Bianca, et al.
Plos One|September 1, 2021
Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trialPaul Jank, Claire Gehlhaar, Bianca Lederer, et al.
British Journal of Cancer|July 21, 2022
pT3 colorectal cancer revisited: a multicentric study on the histological depth of invasion in more than 1000 pT3 carcinomas-proposal for a new pT3a/pT3b subclassificationSebastian Foersch, Corinna Lang-Schwarz, Markus Eckstein, et al.
NPJ Breast Cancer|May 14, 2025
Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantificationKristin Galas, Moritz Gleitsmann, Julia Rey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2024
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical TrialsPaul Jank, Thomas Karn, Marion van Mackelenbergh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2019
Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto TrialSibylle Loibl, Denise Treue, Jan Budczies, et al.
Virchows Archiv : an International Journal of Pathology|April 23, 2026
Optimization of Ki67 digital image analysis in breast cancer by automated tumor area identificationPaul Jank, Maximilian J Krämer, Michael Untch, et al.
Pageof 42